Scientific Bioprocessing, Inc. (SBI), a leader in sensing technology for the life science industry, is sponsoring and participating in an upcoming SelectBio Web Conference focused on the latest advancements in cell culture oxygen and pH sensing.
The “Oxygen and pH Sensing in Cell Culture: The Latest Advances in 2021” web conference will be held virtually on January 12, 2021. Keynote speakers include Dr. Doris Taylor of RegenMedix Technologies, and Ohad Karnieli, Founder and CEO of ADVA Biotechnology.
This virtual event is bringing together subject matter experts from industry and academia to present and discuss the importance and power of real-time oxygen and pH sensing in cell culture and bioprocessing.
“This is a wonderful opportunity for those in the bioprocessing field and the life sciences to hear from the people at the forefront of the bioprocessing automation and sensing revolution,” stated John Moore, President of SBI and webinar panelist. “This is an important discussion about the future of bioprocessing that shouldn’t be missed by anyone with a vested interest in the field.”Dr.
Advancements in cell and gene therapy, regenerative medicine, organ-on-a-chip microfluidics, and other groundbreaking technologies are rapidly transforming drug development processes and needs. While these advances are promising for the industry and patients seeking better therapies and a cure to devastating diseases, challenges remain at the cell culture level. These challenges include high costs, limited deployment of real-time bioprocessing monitoring and controls, and a general lack of experiment reproducibility that causes inefficiency and regulatory challenges.
The publication Nature recently surveyed over 1,500 scientists. The survey found that approximately 70% of scientists failed to reproduce other scientist’s experiments and, amazingly, 50% of the scientists surveyed revealed they could not even repeat their own experiments. Early-stage cell culture reproducibility is critical to greater drug development success and achieving faster speed to market at lower costs to companies and patients.
SBI, along with other forward-thinking companies, are creating a new way forward where cell culture is highly automated, cell conditions are monitored in real-time, and successful drug development outcomes can be more easily replicated across and within labs. Increasing the repeatability of experiments and the consistency of bioprocessing will transform cell culture from what’s now a “craft” that deftly blends art and science into an automated, industrialized, and scalable closed process that will bring more of these innovative technologies to commercialization.
SBI is the primary web conference sponsor and an industry leader in real-time cell culture sensing technology. The company’s optical sensors can be used in virtually any form factor from the smallest microfluidics equipment all the way up to the largest bioreactors. SBI is actively working with a host of partners, including the Advanced Regenerative Manufacturing Institute (ARMI), the University of Virginia, Sudhin Biopharma, the Wake Forest Institute for Regenerative Medicine, and the RegenMed Development Organization (ReMDO), to deploy their optical sensors within a variety of innovative and important projects.
This web conference event will discuss the importance of real-time monitoring of pH and oxygen and how this capability can positively impact a wide range of technologies from 3D organoid models and cell therapy manufacturing to microfluidics, organ-on-a-chip, and spheroids. Event speakers include:
· Alicia Henn, Chief Scientific Officer, BioSpherix, Ltd.
· Dhinakar Kompala, Chairman & CEO, Sudhin Biopharma Co.
· Mrignayani Kotecha, Chief Executive Officer, O2M Technologies, LLC
· Terry Riss, Global Strategic Marketing Manager Cell Health, Promega Corporation
· Thomas Shupe, Assistant Professor, Wake Forest Institute for Regenerative Medicine
· Pawel Swietach, Professor of Physiology, University of Oxford
· Govind Rao, Director, Center for Advanced Sensor Technology and Professor, Chemical, Biochemical and Environmental Engineering, UMBC, Baltimore
· Shiny Rajan, Research Associate, Wake Forest Institute for Regenerative Medicine
· Derek Toms, PostDoctoral Fellow, University of Calgary
· Jake Boy, Senior Application Scientist, Scientific Bioprocessing
Join us on January 12, 2021, for a lively and engaging web conference about the bright future of bioprocessing and how real-time sensing of pH, oxygen, and other cell growth factors can be a catalyst for realizing the promise of these exciting new technologies and therapeutics.